June 2, 2020
June 2, 2020
Boonton, NJ – June 2, 2020 – Enteris BioPharma, Inc., a biotechnology company developing innovative drug products built around its proprietary delivery technologies and a wholly-owned […]
May 4, 2020
May 4, 2020
Accomplished Industry Executive Brings Extensive Business Development Experience and Deep Knowledge of Drug Delivery Technology to Enteris Boonton, NJ – May 4, 2020 – Enteris BioPharma, […]
February 10, 2020
February 10, 2020
Accomplished biopharma and drug development executive to lead expansion of Enteris’ internal and external development programs. Boonton, NJ – February 10, 2020 – Enteris BioPharma, Inc., […]
January 29, 2020
January 29, 2020
Enteris recognized for enhancing positive image of small businesses and service to customers. Award received from the Boonton Award Program, in the Pharmaceutical Company category Recognizes […]
January 7, 2020
January 7, 2020
A transformational 2019 positions Enteris to capitalize on potential of Peptelligence® Acquired by SWK Holdings Corporation; Now Operating as a Wholly Owned Subsidiary Focused on Advancement […]
December 6, 2019
December 6, 2019
Oral KORSUVA 1 mg met primary endpoint with statistically significant reduction in mean worst itching intensity NRS scores vs. placebo after 12-week treatment period (p=0.018) Oral […]
August 27, 2019
August 27, 2019
SWK Holdings Corporation acquires 100% of Enteris’ equity from Victory Park Capital Enteris to operate as an independent, wholly-owned subsidiary of SWK, targeting opportunities to develop […]
KNOWLEDGE CENTER
Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.
LEARN MOREKNOWLEDGE CENTER
Expand your knowledge. The Enteris BioPharma Knowledge Center is a library of educational tools.
LEARN MORE
